220 related articles for article (PubMed ID: 21087649)
1. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.
Makkos Z; Fejes L; Inczédy-Farkas G; Kassai-Farkas A; Faludi G; Lazary J
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):212-7. PubMed ID: 21087649
[TBL] [Abstract][Full Text] [Related]
2. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics of cannabis-induced schizophrenia spectrum disorder].
Makkos Z; Fejes L; Inczédy-Farkas G; Kassai-Farkas A; Faludi G; Lazáry J
Neuropsychopharmacol Hung; 2011 Sep; 13(3):127-38. PubMed ID: 21876221
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics influencing age at onset in psychotic disorders.
Ongür D; Lin L; Cohen BM
Compr Psychiatry; 2009; 50(1):13-9. PubMed ID: 19059508
[TBL] [Abstract][Full Text] [Related]
5. [Cannabis consumption and development of psychosis: state of the art].
Roncero C; Collazos F; Valero S; Casas M
Actas Esp Psiquiatr; 2007; 35(3):182-9. PubMed ID: 17508295
[TBL] [Abstract][Full Text] [Related]
6. Delusions incorporating cannabis use in dually diagnosed patients with a primary psychotic disorder.
Flanders SE
Aust N Z J Psychiatry; 2007 Nov; 41(11):934-6. PubMed ID: 17924247
[TBL] [Abstract][Full Text] [Related]
7. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls.
Dekker N; Smeerdijk AM; Wiers RW; Duits JH; van Gelder G; Houben K; Schippers G; Linszen DH; de Haan L
Psychol Med; 2010 Aug; 40(8):1325-36. PubMed ID: 19917142
[TBL] [Abstract][Full Text] [Related]
8. Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care.
Isaac M; Isaac M; Holloway F
Hum Psychopharmacol; 2005 Apr; 20(3):207-10. PubMed ID: 15682431
[TBL] [Abstract][Full Text] [Related]
9. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
10. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
[TBL] [Abstract][Full Text] [Related]
11. [Related, induced and associated psychiatric disorders to cannabis].
Laqueille X
Rev Prat; 2005 Jan; 55(1):30-4. PubMed ID: 15801394
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
Machielsen M; van der Sluis S; de Haan L
Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
[TBL] [Abstract][Full Text] [Related]
13. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
[TBL] [Abstract][Full Text] [Related]
14. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis.
Dragt S; Nieman DH; Schultze-Lutter F; van der Meer F; Becker H; de Haan L; Dingemans PM; Birchwood M; Patterson P; Salokangas RK; Heinimaa M; Heinz A; Juckel G; Graf von Reventlow H; French P; Stevens H; Ruhrmann S; Klosterkötter J; Linszen DH;
Acta Psychiatr Scand; 2012 Jan; 125(1):45-53. PubMed ID: 21883099
[TBL] [Abstract][Full Text] [Related]
15. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and symptomatological features in chronic psychotic patients according to cannabis use status.
Maremmani I; Lazzeri A; Pacini M; Lovrecic M; Placidi GF; Perugi G
J Psychoactive Drugs; 2004 Jun; 36(2):235-41. PubMed ID: 15369205
[TBL] [Abstract][Full Text] [Related]
17. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
Barrigón ML; Gurpegui M; Ruiz-Veguilla M; Diaz FJ; Anguita M; Sarramea F; Cervilla J
J Psychiatr Res; 2010 May; 44(7):413-20. PubMed ID: 19900684
[TBL] [Abstract][Full Text] [Related]
18. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
[TBL] [Abstract][Full Text] [Related]
19. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
Babatope T; Chotalia J; Elkhatib R; Mohite S; Shah J; Goddu S; Patel RA; Aimienwanu OR; Patel D; Makanjuola T; Okusaga OO
Psychiatr Q; 2016 Dec; 87(4):729-737. PubMed ID: 26875104
[TBL] [Abstract][Full Text] [Related]
20. Suicide attempts by jumping and psychotic illness.
Nielssen O; Glozier N; Babidge N; Reutens S; Andrews D; Gerard A; Malhi GS; Large MM
Aust N Z J Psychiatry; 2010 Jun; 44(6):568-73. PubMed ID: 20482416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
